Filtered By:
Source: The Journal of Clinical Endocrinology and Metabolism
This page shows you your search results in order of date.
Order by Relevance | Date
Total 115 results found since Jan 2013.
Higher Risk of Incident Hyperthyroidism in Patients With Atrial Fibrillation
CONCLUSIONS: Our results provide insight into clinical risk factors for the development of hyperthyroidism in AF patients, as identified by the novel SAD HEC2 score. AF appears to be a common precursor of hyperthyroidism.PMID:37565329 | DOI:10.1210/clinem/dgad448
Source: The Journal of Clinical Endocrinology and Metabolism - August 11, 2023 Category: Endocrinology Authors: Pang-Shuo Huang Jen-Fang Cheng Jien-Jiun Chen Yi-Chih Wang Juey-Jen Hwang Cho-Kai Wu Chia-Ti Tsai Source Type: research
Glucagon-like peptide-1 receptor agonists across the spectrum of heart failure
J Clin Endocrinol Metab. 2023 Jul 6:dgad398. doi: 10.1210/clinem/dgad398. Online ahead of print.ABSTRACTGlucagon-like peptide-1 receptor agonists (GLP-1 RA) have been used to reduce body weight in overweight or people with obesity and to improve glycemic control and cardiovascular outcomes among people with type 2 diabetes (T2D) and a high cardiovascular risk. However, the effects of GLP-1 RA may be modified by the presence of heart failure (HF). In this review, we summarize the evidence for the use of GLP-1 RA across patient's risk with a particular focus in HF. After a careful review of the literature, we challenge the c...
Source: The Journal of Clinical Endocrinology and Metabolism - July 6, 2023 Category: Endocrinology Authors: Jo ão Pedro Ferreira Abhinav Sharma Javed Butler Milton Packer Faiez Zannad Francisco Vasques-N óvoa Adelino Leite-Moreira Jo ão Sérgio Neves Source Type: research
Testosterone replacement therapy in relation with cardiovascular disease in cisgender women and transgender people
CONCLUSION: Use of TTh increased the risk of CVD, CAD and stroke among is cisgender women, but not among transgender people. TTh is becoming more widely accepted in women, and it is the main medical treatment for transgender males. Therefore, use of TTh should be further investigated for the prevention of CVD.PMID:37392459 | DOI:10.1210/clinem/dgad388
Source: The Journal of Clinical Endocrinology and Metabolism - July 1, 2023 Category: Endocrinology Authors: David S Lopez Juwairia S Mulla Danielle El Haddad Md Ibrahim Tahashilder Efstathia Polychronopolou Jacques Baillargeon Yong-Fang Kuo Syed Gilani Wissam I Khalife Source Type: research
Associations of Serum 25(OH)D with Risk of Recurrent Cardiovascular Events in Individuals with Coronary Heart Disease
This study aimed to investigate the associations of serum 25-hydroxyvitamin D [25(OH)D] concentration and the vitamin D receptor (VDR) polymorphisms with the risk of recurrent cardiovascular events in individuals with established CHD.METHODS: A total of 22,571 participants with CHD were included from the UK Biobank. Recurrent cardiovascular events, including myocardial infarction (MI), heart failure (HF), stroke, and CVD mortality, were identified from electronic health records. Cox proportional hazard models were used to calculate hazard ratios (HRs) and 95% confidence intervals (CIs).RESULTS: The median (interquartile ra...
Source: The Journal of Clinical Endocrinology and Metabolism - June 6, 2023 Category: Endocrinology Authors: Xiaoyu Lin Xue Chen Sen Liu Yulei Deng Yuexuan Wang Qi Lu Rui Li Yunjing Ou Qingying Tian Yunfei Liao Guanglin Cui Kun Yang An Pan Gang Liu Source Type: research
Metabolic syndrome and C reactive protein are associated with a reduced myocardial mechano-energetic efficiency
CONCLUSION: Non-diabetic and prediabetic individuals with metabolic syndrome exhibit increased stroke work and myocardial oxygen consumption, and an impaired MEEi, an established predictor of adverse cardiovascular events, and elevated hsCRP levels in combination with metabolic syndrome aggravates the myocardial MEEi impairment.PMID:37235788 | DOI:10.1210/clinem/dgad300
Source: The Journal of Clinical Endocrinology and Metabolism - May 26, 2023 Category: Endocrinology Authors: Chiara M A Cefalo Alessia Riccio Teresa Vanessa Fiorentino Elena Succurro Sofia Miceli Gaia Chiara Mannino Maria Perticone Angela Sciacqua Francesco Andreozzi Giorgio Sesti Source Type: research
Cardio-cerebrovascular Outcomes in MODY, Type 1 Diabetes, and Type 2 Diabetes: A Prospective Cohort Study
CONCLUSIONS: MODY diagnosed by genetic analysis represents higher prevalence than the clinical diagnosis in UK Biobank. The risk of incident cardio-cerebrovascular events in MODY ranks between type 1 diabetes and type 2 diabetes.PMID:37093977 | DOI:10.1210/clinem/dgad233
Source: The Journal of Clinical Endocrinology and Metabolism - April 24, 2023 Category: Endocrinology Authors: Hui-Xuan Wu Tian-Yao Chu Junaid Iqbal Hong-Li Jiang Long Li Yan-Xuan Wu Hou-De Zhou Source Type: research
SGLT-2 Inhibitors: Discrepancy Between MACE Reduction and Incident MI & amp; Stroke
J Clin Endocrinol Metab. 2023 Apr 15:dgad216. doi: 10.1210/clinem/dgad216. Online ahead of print.NO ABSTRACTPMID:37061813 | DOI:10.1210/clinem/dgad216
Source: The Journal of Clinical Endocrinology and Metabolism - April 16, 2023 Category: Endocrinology Authors: David T Broome Source Type: research
